| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.08 | 0.1 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | 0.22 | 0.1 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.048 | 0.1 |